In another meta-analysis involving ten studies with, 656 patients and 3725 controls, the RAD51/G135C polymorphism was associated with increased MDS risk, while no association was observed for acute leukemia (He et al. 2014). This evidence concerns the gene RAD51 and myelodysplastic syndrome.